US2021292835A1PendingUtilityA1

System and methods for massively parallel analysis of nucleic acids in single cells

78
Assignee: GIGAGEN INCPriority: Dec 16, 2010Filed: Jun 2, 2021Published: Sep 23, 2021
Est. expiryDec 16, 2030(~4.4 yrs left)· nominal 20-yr term from priority
C12Q 1/6846C12Q 1/6886C12N 15/1006C40B 50/06C12Q 2600/158C12Q 2600/156C07K 16/00C12N 15/1065C07K 2317/622C12Q 1/6888C12Q 1/6881C12Q 1/6837C12Q 1/6883C12Q 1/6874C12N 15/1075
78
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and systems are provided for massively parallel genetic analysis of single cells in emulsion droplets or reaction containers. Genetic loci of interest are targeted in a single cell using a set of probes, and a fusion complex is formed by molecular linkage and amplification techniques. Methods are provided for high-throughput, massively parallel analysis of the fusion complex in a single cell in a population of at least 10,000 cells. Also provided are methods for tracing genetic information back to a cell using barcode sequences.

Claims

exact text as granted — not AI-modified
1 . A method of amplifying a T cell receptor sequence, comprising:
 (a) isolating each of a plurality of single cells into an individual compartment wherein each individual compartment is a microdroplet in an emulsion;   (b) obtaining transcripts from each of the single cells;   (c) reacting the transcripts from each of the single cells with a set of first probes and a set of second probes,
 i. wherein the set of first probes comprises (1) a first forward probe comprising a sequence complementary to a first subsequence of a first target sequence, and (2) a first reverse probe comprising a sequence complementary to a second subsequence of the first target sequence and a sequence complementary to a non-human, exogenous sequence; 
 ii. wherein the set of second probes comprises (1) a second forward probe comprising a sequence complementary to a first subsequence of a second target sequence, and (2) a second reverse probe comprising a sequence complementary to a second subsequence of the second target sequence and the non-human, exogenous sequence; and 
   (d) performing reverse transcription followed by PCR amplification, thereby generating a fused complex comprising the first target sequence and the second target sequence, wherein the first target sequence is a first gene transcript associated with a T cell.   
     
     
         2 . The method of  claim 1 , further comprising the step of sequencing the fused complex and the step of identifying a T cell based on the sequencing. 
     
     
         3 . The method of  claim 1 , wherein the second target sequence is a barcode sequence. 
     
     
         4 . The method of  claim 3 , wherein the barcode sequence is attached to a bead. 
     
     
         5 . The method of  claim 1 , wherein the first forward probe or the second forward probe is attached to a bead. 
     
     
         6 . The method of  claim 1 , wherein each individual compartment has an average volume of 1 nanoliter (nL). 
     
     
         7 . The method of  claim 1 , wherein the step (a) further comprises introducing an mRNA capture agent and a cell lysis solution into the individual compartments. 
     
     
         8 . The method of  claim 1 , comprising obtaining sequences from at least 10,000 individual cells or at least 5,000 fused complexes. 
     
     
         9 . The method of  claim 1 , wherein step (d) comprises:
 performing overlap extension reverse transcriptase polymerase chain reaction to link the first target sequence and the second target sequence.   
     
     
         10 . The method of  claim 1 , wherein the first target sequence and the second target sequence are different.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.